A, H., HM, Y., S, G., & NB, M. (2015). Comparison of the pharmacokinetics of an oral extended-release capsule formulation of carbidopa-levodopa (IPX066) with immediate-release carbidopa-levodopa (Sinemet(®)), sustained-release carbidopa-levodopa (Sinemet(®) CR), and carbidopa-levodopa-entacapone (Stalevo(®)). Journal of clinical pharmacology, 55(9), 995. https://doi.org/10.1002/jcph.514
Chicago Style (17th ed.) CitationA, Hsu, Yao HM, Gupta S, and Modi NB. "Comparison of the Pharmacokinetics of an Oral Extended-release Capsule Formulation of Carbidopa-levodopa (IPX066) with Immediate-release Carbidopa-levodopa (Sinemet(®)), Sustained-release Carbidopa-levodopa (Sinemet(®) CR), and Carbidopa-levodopa-entacapone (Stalevo(®))." Journal of Clinical Pharmacology 55, no. 9 (2015): 995. https://doi.org/10.1002/jcph.514.
MLA (9th ed.) CitationA, Hsu, et al. "Comparison of the Pharmacokinetics of an Oral Extended-release Capsule Formulation of Carbidopa-levodopa (IPX066) with Immediate-release Carbidopa-levodopa (Sinemet(®)), Sustained-release Carbidopa-levodopa (Sinemet(®) CR), and Carbidopa-levodopa-entacapone (Stalevo(®))." Journal of Clinical Pharmacology, vol. 55, no. 9, 2015, p. 995, https://doi.org/10.1002/jcph.514.